International Stem Cell Corp Stock OTC Bulletin Board
Equities
ISCO
US4603781026
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Financials (USD)
Sales 2022 | 8.18M | Sales 2023 | 7.79M | Capitalization | 496K |
---|---|---|---|---|---|
Net income 2022 | - | Net income 2023 | - | EV / Sales 2022 | 0.61 x |
Net Debt 2022 | 3.53M | Net Debt 2023 | 2.59M | EV / Sales 2023 | 0.4 x |
P/E ratio 2022 |
-4.35
x | P/E ratio 2023 |
-3.79
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 27.91% |
Managers | Title | Age | Since |
---|---|---|---|
Andrey Semechkin
CEO | Chief Executive Officer | 64 | 08-11-30 |
Russell Kern
DFI | Director of Finance/CFO | 38 | 08-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Russell Kern
DFI | Director of Finance/CFO | 38 | 08-09-30 |
Paul Maier
BRD | Director/Board Member | 76 | 07-06-30 |
Andrey Semechkin
CEO | Chief Executive Officer | 64 | 08-11-30 |
1st Jan change | Capi. | |
---|---|---|
+25.69% | 47.86B | |
+46.90% | 41.42B | |
-3.46% | 40.66B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+0.17% | 12.15B | |
+28.07% | 12.14B | |
-1.24% | 11.99B |
- Stock Market
- Equities
- ISCO Stock
- ISCO Stock